Please try another search
For the six months ended 30 June 2019, JoBen Bio-Medical Co Ltd revenues decreased 38% to NT$54.8M. Net loss increased 26% to NT$67.7M. Revenues reflect Basswood Income segment decrease of 51% to NT$5.6M, Cultivation of Antrodia Basswood segment decrease of 67% to NT$2.7M. Higher net loss reflects Other Operating Income/Expense decrease of 80% to NT$4.8M (income).
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Revenue | 54.84 | 103.52 | 88.89 | 67.88 |
Gross Profit | 8.62 | 23.18 | 20.56 | 17.69 |
Operating Income | -84.84 | -82.12 | -70.67 | -74.63 |
Net Income | -67.69 | -69.56 | -53.77 | -60.86 |
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Assets | 1528.87 | 1488.97 | 1626.4 | 1714.36 |
Total Liabilities | 644.58 | 536.79 | 603.99 | 609.72 |
Total Equity | 884.29 | 952.18 | 1022.4 | 1104.64 |
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | -50.37 | -174.7 | -135.88 | 108.69 |
Cash From Investing Activities | -6.91 | -37.94 | -78.59 | -110.74 |
Cash From Financing Activities | -7.01 | -53.31 | -16.37 | 109.71 |
Net Change in Cash | -64.32 | -265.9 | -230.03 | 103.08 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review